Citi maintains Eisai at 'buy' with a price target of ¥9.3K
An analyst from Citi maintained Eisai (TYO: 4523) at 'buy' with a price target of ¥9.3K from a prior price target of ¥10.8K. Prior to this rating, Eisai had 6 buy ratings, 7 hold...
Neutral
or
Eisai News & Analysis
-
-
UBS initiates coverage of Eisai at 'neutral' with a price target of ¥8.3K
An analyst from UBS initiated coverage of Eisai (TYO: 4523) at 'neutral' with a price target of ¥8.3K. Prior to this rating, Eisai had 5 buy ratings, 4 hold ratings, and 2 sell...
-
Jefferies maintains Eisai at 'hold' with a price target of JPY9.1K
An analyst from Jefferies maintained Eisai (TYO: 4523) at 'hold' with a price target of JPY9.1K from a prior price target of JPY9.9K. Prior to this rating, Eisai had 5 buy ratings, 6 hold...
-
Bernstein maintains Eisai at 'outperform' with a price target of JPY11.1K
An analyst from Bernstein maintained Eisai (TYO: 4523) at 'outperform' with a price target of JPY11.1K. Prior to this rating, Eisai had 5 buy ratings, 6 hold ratings, and 2 sell...
-
JPMorgan maintains Eisai at 'overweight' with a price target of JPY12600.00
An analyst from JPMorgan maintained Eisai (TYO: 4523) at 'overweight' with a price target of JPY12600.00. Prior to this rating, Eisai had 5 buy ratings, 6 hold ratings, and 2 sell...
-
JPMorgan maintains Eisai at 'overweight' with a price target of JPY12600.00
An analyst from JPMorgan maintained Eisai (TYO: 4523) at 'overweight' with a price target of JPY12600.00 from a prior price target of JPY12000.00. Prior to this rating, Eisai had 5 buy...
-
Jefferies maintains Eisai at 'hold' with a price target of JPY9600.00
An analyst from Jefferies maintained Eisai (TYO: 4523) at 'hold' with a price target of JPY9600.00 from a prior price target of JPY8000.00. Prior to this rating, Eisai had 5 buy ratings, 6...
-
JPMorgan maintains Eisai at 'overweight' with a price target of JPY12000.00
An analyst from JPMorgan maintained Eisai (TYO: 4523) at 'overweight' with a price target of JPY12000.00 from a prior price target of JPY11000.00. Prior to this rating, Eisai had 5 buy...
-
Credit Suisse maintains Eisai at 'neutral' with a price target of JPY9500.00
An analyst from Credit Suisse maintained Eisai (TYO: 4523) at 'neutral' with a price target of JPY9500.00. Prior to this rating, Eisai had 5 buy ratings, 7 hold ratings, and 2 sell...
-
Biogen shares jump after FDA advisory panel backs Alzheimer's drug
Investing.com -- Shares in Biogen Inc (NASDAQ:BIIB) surged in premarket trading on Monday after an advisory panel to U.S. regulators gave their support to the early-stage usage of an...
-
Credit Suisse maintains Eisai at 'neutral' with a price target of JPY9500.00
An analyst from Credit Suisse maintained Eisai (TYO: 4523) at 'neutral' with a price target of JPY9500.00 from a prior price target of JPY8500.00. Prior to this rating, Eisai had 6 buy...
-
Bernstein maintains Eisai at 'outperform' with a price target of JPY9800.00
An analyst from Bernstein maintained Eisai (TYO: 4523) at 'outperform' with a price target of JPY9800.00. Prior to this rating, Eisai had 4 buy ratings, 5 hold ratings, and 3 sell...
-
Citi upgrades Eisai to 'buy' with a price target of JPY10800.00
An analyst from Citi upgraded Eisai (TYO: 4523) from 'neutral' to 'buy' with a price target of JPY10800.00 from a prior price target of JPY8300.00. Prior to this rating, Eisai had 5 buy...
-
Nomura/Instinet maintains Eisai at 'buy' with a price target of JPY13200.00
An analyst from Nomura/Instinet maintained Eisai (TYO: 4523) at 'buy' with a price target of JPY13200.00 from a prior price target of JPY13000.00. Prior to this rating, Eisai had 4 buy...
-
Biogen gains as analysts reflect positively on Leqembi's approval, pricing
By Senad Karaahmetovic On Friday, the United States Food and Drug Administration (FDA) officially approved Leqembi, a new drug developed by Biogen (NASDAQ:BIIB) and Japan-based Eisai...
-
Roche shares fall after Alzheimer's drug trials fail to meet primary goals
By Scott Kanowsky Investing.com -- Roche Holding AG Participation (SIX:ROG) says two long-awaited late-stage studies showed that its Alzheimer's disease treatment failed to stem a slide in...
-
Midday Movers: Biogen, Apple, DocuSign and More
By Liz Moyer Investing.com -- U.S. stocks rose after the Bank of England stepped in to stabilize the British pound. Here are the midday movers for Sept. 28: Biogen Inc (NASDAQ:BIIB) shares...
-
U.S. Stocks Rise as Bond Yields Ease
By Liz Moyer Investing.com -- U.S. stocks rose as investors tried to reverse a multi-day losing streak sparked by global growth concerns. At 09:51 ET (13:51 GMT), the Dow Jones Industrial...
-
Analysts Discuss Implications for Eli Lilly After Biogen's Big Win
By Senad Karaahmetovic Shares of Eli Lilly (NYSE:LLY) are up almost 8% in sympathy with Biogen (NASDAQ:BIIB), which trades about 54% higher in pre-open Wednesday. Biogen announced that its...
-
Biogen Surges After 'Best-Case' Alzheimer's Drug Trial Results; Stock Earns Several Upgrades
By Senad Karaahmetovic Shares of Biogen (NASDAQ:BIIB) are trading sharply higher in pre-market Wednesday after the company announced positive topline results for its experimental Alzheimer’s...
-
Japan shares lower at close of trade; Nikkei 225 down 1.15%
Investing.com – Japan equities were lower at the close on Wednesday, as losses in the Gas & Water, Paper & Pulp and Marine Transport sectors propelled shares lower. At the close in Tokyo,...
-
Japan shares higher at close of trade; Nikkei 225 up 1.92%
Investing.com – Japan equities were higher at the close on Wednesday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 0.83%
Investing.com – Japan equities were higher at the close on Thursday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.30%
Investing.com – Japan equities were lower at the close on Thursday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 1.25%
Investing.com – Japan equities were higher at the close on Friday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 1.25%
Investing.com – Japan equities were lower at the close on Monday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.98%
Investing.com – Japan equities were lower at the close on Friday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 2.25%
Investing.com – Japan equities were higher at the close on Monday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.63%
Investing.com – Japan equities were lower at the close on Friday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.64%
Investing.com – Japan equities were lower at the close on Monday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.07%
Investing.com – Japan equities were lower at the close on Wednesday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 0.66%
Investing.com – Japan equities were higher at the close on Friday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.03%
Investing.com – Japan equities were lower at the close on Wednesday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.19%
Investing.com – Japan equities were lower at the close on Friday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 0.96%
Investing.com – Japan equities were higher at the close on Tuesday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.03%
Investing.com – Japan equities were lower at the close on Friday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 0.34%
Investing.com – Japan equities were higher at the close on Thursday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.35%
Investing.com – Japan equities were lower at the close on Wednesday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares lower at close of trade; Nikkei 225 down 0.19%
Investing.com – Japan equities were lower at the close on Tuesday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in Tokyo, the...
-
Japan shares higher at close of trade; Nikkei 225 up 0.12%
Investing.com – Japan equities were higher at the close on Wednesday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Japanese shares gain tracking U.S. futures; tech and pharma stocks boost
TOKYO, Jan 25 (Reuters) - Japanese shares rose on Monday, erasing early losses, led by tech and pharma stocks as U.S. futures rose on hopes that lawmakers would soon pass a massive economic...
-
Japanese shares track U.S. futures higher, tech leads gains
TOKYO, Jan 25 (Reuters) - Japanese shares shook off early weakness on Monday, led by tech and pharma stocks, as U.S. futures rose on hopes that lawmakers would soon pass a massive economic...
-
Nikkei ends at 30-yr high as drug makers rally on COVID-19 treatment news
TOKYO, Jan 12 (Reuters) - Japan's benchmark Nikkei share average inched up to close at a fresh three-decade high on Tuesday, as drug makers led the charge on a report that Chugai...
-
Drug makers help Nikkei scale fresh 3-decade high
By Junko Fujita TOKYO, Jan 12 (Reuters) - Japan's benchmark Nikkei share average recovered from early falls on Tuesday to hit a fresh three-decade high, with drug makers leading the charge...
-
Japan shares higher at close of trade; Nikkei 225 up 2.05%
Investing.com – Japan equities were higher at the close on Monday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
CORRECTED-Nikkei jumps to 29-year high, Honda leads carmakers on upbeat earnings
(Corrects Topix close in fourth paragraph to 1,681.90, not 1,6781.90)By Hideyuki SanoTOKYO, Nov 9 (Reuters) - Japan's Nikkei share average on Monday reached a high last seen almost three...
-
Japan shares higher at close of trade; Nikkei 225 up 2.12%
Investing.com – Japan equities were higher at the close on Monday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares higher. At the close in Tokyo, the...
-
Nikkei rallies to 29-year high, Honda leads carmakers on upbeat earnings
By Hideyuki SanoTOKYO, Nov 9 (Reuters) - Japan's Nikkei share average on Monday reached a high last seen almost three decades ago, after Joe Biden secured a victory in the U.S. Presidential...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
